Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001583098-26-000004

Director sold 15,481 shares at an average $8.40 ($129,994)

  • Director acquired 25,344 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

DeGolyer Donald W · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-30 Grant or award : show line 1 in the form 10b5-1 +25,344 145,202 D
2026-05-01 Sale : show line 2 in the form 10b5-1 −14,527 $8.36 $121,446 130,675 D
2026-05-01 Sale : show line 3 in the form 10b5-1 −954 $8.96 $8,548 129,721 D
Open-market sales · 15,481 sh · avg $8.40 · $129,994

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-30 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +11,296 11,296 D
Loading xslF345X06/wk-form4_1777930221.xml…